These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 37360004)

  • 1. Role of Gene Mutations in Acute Myeloid Leukemia: A Review Article.
    Singh H; Kumar M; Kanungo H
    Glob Med Genet; 2023 Jun; 10(2):123-128. PubMed ID: 37360004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
    Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M
    J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and laboratory features of seven patients with acute myeloid leukemia (AML)-M2/M3 and elevated myeloblasts and abnormal promyelocytes.
    He G; Wang C; Li Q; Tan H; Chen F; Huang Z; Yu B; Zheng L; Zheng R; Liu D
    Cancer Cell Int; 2014; 14(1):111. PubMed ID: 25678855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Familial platelet disorder with predisposition to myeloid leukemia (FPD/AML): a case report and literature review].
    Zhang RR; Chen XJ; Ren YY; Yang WY; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):308-312. PubMed ID: 33979975
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental drugs in clinical trials for acute myeloid leukemia: innovations, trends, and opportunities.
    Gołos A; Góra-Tybor J; Robak T
    Expert Opin Investig Drugs; 2023 Jan; 32(1):53-67. PubMed ID: 36669827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Molecular Targeted Therapeutic Drugs in Treatment of Glioblastoma: A Review Article.
    Singh H
    Glob Med Genet; 2023 Jun; 10(2):42-47. PubMed ID: 37077370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of acute myeloid leukemia by the revised fourth edition World Health Organization criteria: a retrospective single-institution study with appraisal of the new entities of acute myeloid leukemia with gene mutations in NPM1 and biallelic CEBPA.
    Kansal R
    Hum Pathol; 2019 Aug; 90():80-96. PubMed ID: 31077683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia.
    Bănescu C; Tripon F; Muntean C
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia.
    Pulikkan JA; Castilla LH
    Front Oncol; 2018; 8():129. PubMed ID: 29755956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic abnormalities and challenges in the treatment of acute myeloid leukemia.
    Kumar CC
    Genes Cancer; 2011 Feb; 2(2):95-107. PubMed ID: 21779483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia.
    Ribeiro S; Eiring AM; Khorashad JS
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleophosmin 1 Mutations in Acute Myeloid Leukemia.
    Zarka J; Short NJ; Kanagal-Shamanna R; Issa GC
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32545659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
    Preudhomme C; Warot-Loze D; Roumier C; Grardel-Duflos N; Garand R; Lai JL; Dastugue N; Macintyre E; Denis C; Bauters F; Kerckaert JP; Cosson A; Fenaux P
    Blood; 2000 Oct; 96(8):2862-9. PubMed ID: 11023523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of recurrent gene mutations in acute myeloid leukemia.
    Yu J; Li Y; Zhang D; Wan D; Jiang Z
    Exp Hematol Oncol; 2020; 9():4. PubMed ID: 32231866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal architecture of secondary acute myeloid leukemia.
    Walter MJ; Shen D; Ding L; Shao J; Koboldt DC; Chen K; Larson DE; McLellan MD; Dooling D; Abbott R; Fulton R; Magrini V; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Fan X; Grillot M; Witowski S; Heath S; Frater JL; Eades W; Tomasson M; Westervelt P; DiPersio JF; Link DC; Mardis ER; Ley TJ; Wilson RK; Graubert TA
    N Engl J Med; 2012 Mar; 366(12):1090-8. PubMed ID: 22417201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular Genetic Testing for Acute Myeloid Leukemia].
    Janečková V; Semerád L; Ježíšková I; Dvořáková D; Čulen M; Šustková Z; Mayer J; Ráčil Z
    Klin Onkol; 2016; 29(6):411-418. PubMed ID: 27951719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of acute myeloid leukemia: a diverse disease with new perspectives.
    Thol F; Ganser A
    Front Med China; 2010 Dec; 4(4):356-62. PubMed ID: 21125345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and genomic landscapes in secondary & therapy related acute myeloid leukemia.
    Goel H; Rahul E; Gupta I; Chopra A; Ranjan A; Gupta AK; Meena JP; Viswanathan GK; Bakhshi S; Misra A; Hussain S; Kumar R; Singh A; Rath GK; Sharma A; Mittan S; Tanwar P
    Am J Blood Res; 2021; 11(5):472-497. PubMed ID: 34824881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia.
    Strickland SA; Shaver AC; Byrne M; Daber RD; Ferrell PB; Head DR; Mohan SR; Mosse CA; Moyo TK; Stricker TP; Vnencak-Jones C; Savona MR; Seegmiller AC
    Leuk Res; 2018 Feb; 65():67-73. PubMed ID: 29310020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.